about
Fexinidazole: a potential new drug candidate for Chagas diseaseBenznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatmentsNutritional Status Driving Infection by Trypanosoma cruzi: Lessons from Experimental Animals.Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas diseaseLeukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infectionLow doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruziEnalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi.Doxycycline and Benznidazole Reduce the Profile of Th1, Th2, and Th17 Chemokines and Chemokine Receptors in Cardiac Tissue from Chronic Trypanosoma cruzi-Infected Dogs.The Effects of the Combination of a Refined Carbohydrate Diet and Exposure to Hyperoxia in Mice.CXCL-16, IL-17, and bone morphogenetic protein 2 (BMP-2) are associated with overweight and obesity conditions in middle-aged and elderly womenMolecular mechanisms of myocarditis caused by Trypanosoma cruzi.Impairment of Interleukin-17A Expression in Canine Visceral Leishmaniosis is Correlated with Reduced Interferon-γ and Inducible Nitric Oxide Synthase Expression.Expression and production of cardiac angiogenic mediators depend on the Trypanosoma cruzi-genetic population in experimental C57BL/6 mice infection.Modulation of inflammatory and oxidative status by exercise attenuates cardiac morphofunctional remodeling in experimental Chagas cardiomyopathy.Analysis of bioactivities and chemical composition of Ziziphus joazeiro Mart. using HPLC-DAD.Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice.Trypanosoma cruzi antigens induce inflammatory angiogenesis in a mouse subcutaneous sponge model.Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with Trypanosoma cruziEffects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole.Therapeutic responses to different anti-Trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock.Trypanosoma cruzi infection induces morphological reorganization of the myocardium parenchyma and stroma, and modifies the mechanical properties of atrial and ventricular cardiomyocytes in rats.Anti-adrenergic and muscarinic receptor autoantibodies in a canine model of Chagas disease and their modulation by benznidazole.Use of fluorescence in a modified disector method to estimate the number of myocytes in cardiac tissue.Elemental mapping of cardiac tissue by scanning electron microscopy and energy dispersive X-ray spectroscopy: proof of principle in Chaga's disease myocarditis model.Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice.Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection.Lycopene pretreatment improves hepatotoxicity induced by acetaminophen in C57BL/6 mice.Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.Modulation of oxidative and inflammatory cardiac response by nonselective 1- and 2-cyclooxygenase inhibitor and benznidazole in mice.Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection.Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy.Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia.Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1.High-Fat Diet Increases HMGB1 Expression and Promotes Lung Inflammation in Mice Subjected to Mechanical Ventilation.Ethics in the publication of studies on human visceral leishmaniasis in Brazilian periodicalsPlasma Concentrations and Role of Macrophage Inflammatory Protein–1α during ChronicSchistosoma mansoniInfection in Humans
P50
Q28484826-F6C80623-84B5-411F-90B3-881398C1DB23Q28535357-081DB443-70E6-40FD-936A-240613CE3659Q33902186-CF7791E7-E5A0-4932-ABC0-3539BB62CB7CQ34058185-3A29AEDE-31BA-4D5E-A718-CE037A897D9DQ34128916-C6A769A1-FF7B-4C4A-8792-6B4893B607CBQ34531351-44E6C12E-4F19-4F46-B4BF-C84A9C8A9926Q36075925-8205CC68-498E-41F7-A0E1-EF43BF186C75Q36436221-D466C814-51A3-4E0A-8EDA-34251B64246FQ37256759-0DACFAE1-A262-4901-A0B0-AC92506A6AB1Q37497162-57E2A258-1EBA-4957-8C0B-B59214F326D4Q37693965-19AE3254-A025-4B2F-9784-0898FFDF7C1CQ38426905-CB84A272-9284-4479-8266-88A0135F4125Q40332332-F558154E-9666-4981-8C81-C0603E44208FQ40412764-105F6D01-F26D-4D15-B063-B14A6461700AQ40730320-41AAD984-6C8A-4B83-AF11-476F6D8157BEQ41229135-918CCDF4-7344-411B-9FC1-17EC1162455CQ41286010-0A626AF7-34EF-4A02-B244-7B622EDD7B1FQ41759474-C75171E6-0A62-44BB-B66A-5D95A9CADCF9Q42102813-BE885DC9-24DE-42E0-A589-AF10DFB7EC2BQ42111347-E5869FB3-3F93-4BCB-9311-0139CE8E6133Q43255630-043CC082-96C5-48CE-B3D6-B0C7D840AE5FQ43584085-52C91609-6934-496F-A4DA-9D2A9F59B706Q43807373-16E0A329-39E6-4327-9BC0-0A0C538AA918Q43887256-1B4A4742-8BA2-4576-BE87-122F8A19C84FQ44476342-04AE76EC-D9E6-4B7D-8550-030D50779D15Q44754935-47729E83-7523-468D-88ED-5BB7555EEFE2Q44931932-756DDE73-2EFF-4A66-A429-675F9B7D942BQ45186058-3D77242B-D28D-48F1-98C6-54B3D0627639Q46063891-55FB3163-21AB-44F5-9453-5406578C58F9Q46320666-B8AADD92-3D8E-4AC8-BB9B-A45ED1FAA61DQ46439250-8EA934F7-E1B0-48D8-B752-AF135B105ED6Q46613780-494C5881-F3FB-494C-A712-99CCC3344F7CQ46710618-49C7DEBC-7031-472A-8E54-34FD8E115A14Q46971295-281AD219-9364-4638-9B97-C273A331E183Q47912416-F6640158-65C0-42D4-8E60-A0BC28B03B5DQ48924555-9238A419-EE94-4698-83B5-289684B2A38AQ51466555-EA02583F-5734-4F0F-BC24-11B2C1DC1B30Q52721482-410279F5-F2D2-4B36-AF20-3435BE1D9C21Q56777999-A8E91C96-E6B0-4BFC-8A53-DABA04A91C8AQ57019177-07A29D19-2BC6-489D-8672-9A4B2CA31110
P50
description
researcher ORCID ID = 0000-0002-6685-6229
@en
name
André Talvani
@ast
André Talvani
@en
André Talvani
@nl
type
label
André Talvani
@ast
André Talvani
@en
André Talvani
@nl
prefLabel
André Talvani
@ast
André Talvani
@en
André Talvani
@nl
P31
P496
0000-0002-6685-6229